589
Views
1
CrossRef citations to date
0
Altmetric
CLINICAL: RESEARCH ARTICLE

Early experience with universal SARS-CoV-2 testing in a New York-based reproductive endocrinology ‎practice

ORCID Icon, , , , ORCID Icon, , ORCID Icon & ORCID Icon show all
Pages 144-150 | Received 30 Nov 2020, Accepted 25 Jan 2021, Published online: 16 Mar 2021

References

  • Alviggi C, Esteves SC, Orvieto R, Conforti A, La Marca A, Fischer R, Andersen CY, Bühler K, Sunkara SK, Polyzos NP, et al. 2020. COVID-19 and assisted reproductive technology services: repercussions for patients and proposal for individualized clinical management. Reprod Biol Endocrinol. 18:1. doi:10.1186/s12958-020-00605-z.
  • Armstrong SC, Showell M, Stewart EA, Rebar RW, Vanderpoel S, Farquhar CM. 2017. Baseline anatomical assessment of the uterus and ovaries in infertile women: A systematic review of the evidence on which assessment methods are the safest and most effective in terms of improving fertility outcomes. Hum Reprod Update. 23(5):534–547. doi:10.1093/humupd/dmx019.
  • ASRM Covid-19 Task Force. Patient management and clinical recommendations during the coronavirus (COVID-19) pandemic | ASRM [Internet]. [accessed 2021 Jan 14]. https://www.asrm.org/news-and-publications/covid-19/statements/patient-management-and-clinical-recommendations-during-the-coronavirus-covid-19-pandemic/
  • Bortoletto P, Romanski PA, Stewart J, Schattman G, Rosenwaks Z. 2020. Universal severe acute respiratory syndrome coronavirus 2 (sars-cov-2) testing in a New York city reproductive medicine practice. Fertil Steril. 114(3):e17. doi:10.1016/j.fertnstert.2020.08.073.
  • Choi B, Choudhary MC, Regan J, Sparks JA, Padera RF, Qiu X, Solomon IH, Kuo -H-H, Boucau J, Bowman K, et al. 2020. Persistence and evolution of SARS-CoV-2 in an immunocompromised host. N Engl J Med. 383(23):2291–2293. doi:10.1056/NEJMc2031364.
  • De Santis L, Anastasi A, Cimadomo D, Klinger FG, Licata E, Pisaturo V, Sosa Fernandez L, Scarica C. 2020. COVID-19: the perspective of Italian embryologists managing the IVF laboratory in pandemic emergency. Hum Reprod. 35(4):1004–1005. doi:10.1093/humrep/deaa074.
  • Dellino M, Minoia C, Paradiso AV, De Palo R, Silvestris E. 2020. Fertility preservation in cancer patients during the coronavirus (COVID-19) pandemic. Front Oncol. 10:1009. doi:10.3389/fonc.2020.01009.
  • Foulk RA, Sakkas D, Kayali R, Valbuena D, Simon C, Cuzzi J. 2020. SARS-COV-2 herd immunity, infective and naïve incidence in fertility clinics after pandemic lockdown. A multicenter study. Fertil Steril. 114(3):e539. doi:10.1016/j.fertnstert.2020.09.069.
  • Gandhi RT, Lynch JB, Del Rio C. 2020. Mild or moderate covid-19. Solomon CG, editor. N Engl J Med. 383:1757-1766 doi: 10.1056/NEJMcp2009249 2009249.
  • Katz-Jaffe MG, Henry L, McCubbin N, Tucci R, Mann RS, McReynolds S, Schoolcraft WB. 2020. A comprehensive covid-19 risk mitigation strategy for safe patient care and staff wellness during a global pandemic. Fertil Steril. 114(3):e534–e535. doi:10.1016/j.fertnstert.2020.09.058.
  • La Marca A, Niederberger C, Pellicer A, Nelson SM. 2020. COVID-19: lessons from the Italian reproductive medical experience. Fertil Steril. 113(5):920–922. doi:10.1016/j.fertnstert.2020.03.021.
  • Prados N, González-Ravina C, Vergara V, Herrero J, Cruz M, Requena A. 2020. risk factor analysis for SARS-COV-2 seropositivity within assisted reproductive. Fertil Steril. 114(3):e542. doi:10.1016/j.fertnstert.2020.09.077.
  • R Development Core Team. 2013. R: A language and environment for statistical computing. R Found Stat Comput Vienna Austria. 0:{ISBN} 3-900051-07–0.
  • Robles A, Robles BN, Gemmell LC, Brady PC, Forman EJ, Williams Z. 2020. Universal screening oF COVID-19 in asymptomatic patients starting fertility treatment in New York city. Fertil Steril. 114(3):e179. doi:10.1016/j.fertnstert.2020.08.509.
  • Romanski PA, Bortoletto P, Rosenwaks Z, Schattman GL. 2020. Delay in IVF treatment up to 180 days does not affect pregnancy outcomes in women with diminished ovarian reserve. Hum Reprod. 35(7):1630–1636. doi:10.1093/humrep/deaa137.
  • Rosenberg ES, Tesoriero JM, Rosenthal EM, Chung R, Barranco MA, Styer LM, Parker MM, John Leung SY, Morne JE, Greene D, et al. 2020. Cumulative incidence and diagnosis of SARS-CoV-2 infection in New York. Ann Epidemiol. 48:23–29.e4. doi:10.1016/j.annepidem.2020.06.004.
  • Seidman DS, Kahane A, Shulman A, Schiff E, Shavit T. 2020. Is universal screening of IVF patients for SARS-COV-2 justified? Fertil Steril. 114(3):e534. doi:10.1016/j.fertnstert.2020.09.056.
  • Turner JS, Day A, Alsoussi WB, Liu Z, O’Halloran JA, Presti RM, Patterson BK, Whelan SPJ, Ellebedy AH, Mudd PA. 2021. SARS-CoV-2 Viral RNA shedding for more than 87 days in an individual with an impaired CD8+ T cell response. Front Immunol. 11:3597. doi:10.3389/fimmu.2020.618402.
  • Widders A, Broom A, Broom J. 2020. SARS-CoV-2: the viral shedding vs infectivity dilemma. Infect Dis Heal. 25(3):210–215. doi:10.1016/j.idh.2020.05.002.
  • Zambrano LD, Ellington S, Strid P, Galang RR, Oduyebo T, Tong VT, Woodworth KR, Nahabedian JF, Azziz-Baumgartner E, Gilboa SM, et al. 2020. Update: characteristics of symptomatic women of reproductive age with laboratory-confirmed SARS-CoV-2 infection by pregnancy status — United STATES, January 22–October 3, 2020. MMWR Morb Mortal Wkly Rep. 69(44):1641–1647. doi:10.15585/mmwr.mm6944e3.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.